149 related articles for article (PubMed ID: 21062313)
21. Pharmacokinetics after intravenous, subcutaneous, and oral administration of enrofloxacin to alpacas.
Gandolf AR; Papich MG; Bringardner AB; Atkinson MW
Am J Vet Res; 2005 May; 66(5):767-71. PubMed ID: 15934603
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of enrofloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio.
Fang X; Liu X; Liu W; Lu C
J Vet Pharmacol Ther; 2012 Aug; 35(4):397-401. PubMed ID: 21913940
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of marbofloxacin in blue and gold macaws (Ara ararauna).
Carpenter JW; Hunter RP; Olsen JH; Henry H; Isaza R; Koch DE
Am J Vet Res; 2006 Jun; 67(6):947-50. PubMed ID: 16740085
[TBL] [Abstract][Full Text] [Related]
24. Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves.
Ismail M; El-Kattan YA
Res Vet Sci; 2007 Jun; 82(3):398-404. PubMed ID: 17118414
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits.
Fernández-Varón E; Marin P; Escudero E; Vancraeynest D; Cárceles CM
J Vet Pharmacol Ther; 2007 Feb; 30(1):18-24. PubMed ID: 17217396
[TBL] [Abstract][Full Text] [Related]
26. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction.
Peyrou M; Bousquet-Melou A; Laroute V; Vrins A; Doucet MY
J Vet Pharmacol Ther; 2006 Oct; 29(5):337-44. PubMed ID: 16958777
[TBL] [Abstract][Full Text] [Related]
27. Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs.
Messenger KM; Papich MG; Blikslager AT
J Vet Pharmacol Ther; 2012 Oct; 35(5):452-9. PubMed ID: 21913941
[TBL] [Abstract][Full Text] [Related]
28. Some pharmacokinetic indices of oral fluconazole administration to koalas (Phascolarctos cinereus) infected with cryptococcosis.
Govendir M; Black LA; Jobbins SE; Kimble B; Malik R; Krockenberger MB
J Vet Pharmacol Ther; 2016 Aug; 39(4):412-5. PubMed ID: 26667113
[TBL] [Abstract][Full Text] [Related]
29. In vitro binding of cefovecin to plasma proteins in Australian marsupials and plasma concentrations of cefovecin following single subcutaneous administration to koalas (Phascolarctos cinereus).
Gharibi S; Vogelnest L; Govendir M
Aust Vet J; 2019 Mar; 97(3):75-80. PubMed ID: 30809814
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of enrofloxacin and marbofloxacin in Japanese quails and common pheasants.
Lashev LD; Dimitrova DJ; Milanova A; Moutafchieva RG
Br Poult Sci; 2015 Apr; 56(2):255-61. PubMed ID: 25567298
[TBL] [Abstract][Full Text] [Related]
31. Influence of Pasteurella multocida infection on the pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in rabbits.
Abo-el-Sooud K; Goudah A
J Vet Pharmacol Ther; 2010 Feb; 33(1):63-8. PubMed ID: 20444027
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic properties of enrofloxacin in rabbits.
Broome RL; Brooks DL; Babish JG; Copeland DD; Conzelman GM
Am J Vet Res; 1991 Nov; 52(11):1835-41. PubMed ID: 1664673
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats.
Dova SW; San Andrés MD; González F; San Andrés MI; De Lucas JJ; Rodríguez C
Vet J; 2007 Sep; 174(2):425-7. PubMed ID: 16807010
[TBL] [Abstract][Full Text] [Related]
34. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
Cole LK; Papich MG; Kwochka KW; Hillier A; Smeak DD; Lehman AM
Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587
[TBL] [Abstract][Full Text] [Related]
35. Dispositions and residue depletion of enrofloxacin and its metabolite ciprofloxacin in muscle tissue of giant freshwater prawns (Macrobrachium rosenbergii).
Poapolathep A; Jermnak U; Chareonsan A; Sakulthaew C; Klangkaew N; Sukasem T; Kumagai S
J Vet Pharmacol Ther; 2009 Jun; 32(3):229-34. PubMed ID: 19646086
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.
Sidhu PK; Landoni MF; Aliabadi MH; Toutain PL; Lees P
J Vet Pharmacol Ther; 2011 Aug; 34(4):376-87. PubMed ID: 21091727
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches.
de Lucas JJ; Rodríguez C; Waxman S; González F; Uriarte I; San Andrés MI
Vet J; 2005 Nov; 170(3):364-8. PubMed ID: 16266851
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of danofloxacin 18% in lactating sheep and goats.
Escudero E; Cárceles CM; Fernandez-varon E; Marin P; Benchaoui H
J Vet Pharmacol Ther; 2007 Dec; 30(6):572-7. PubMed ID: 17991226
[TBL] [Abstract][Full Text] [Related]
39. Disposition of marbofloxacin in vulture (Gyps fulvus) after intravenous administration of a single dose.
Garcia-Montijano M; Waxman S; de Lucas JJ; Luaces I; de San Andrés MD; Rodríguez C
Res Vet Sci; 2011 Apr; 90(2):288-90. PubMed ID: 20605034
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration.
Gharibi S; Kimble B; Vogelnest L; Barnes J; Stadler CK; Govendir M
J Vet Pharmacol Ther; 2017 Dec; 40(6):675-681. PubMed ID: 28455999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
